March 8 (Reuters) - Exopharm ( EXOPF ):

* SIGNS BINDING AGREEMENT TO ACQUIRE TRYP THERAPEUTICS

* EXOPHARM INTENDS TO RAISE UP TO A$6.5 MILLION VIA A PUBLIC

OFFER

* UNDERTAKEN INTERIM CAPITAL RAISE BY WAY OF CONVERTIBLE

NOTE OF

A$3.39 MILLION

* ACQUISITION WILL AMOUNT TO SIGNIFICANT CHANGE TO NATURE

AND

SCALE OF CO'S ACTIVITIES

* ISSUE PRICE OF A$0.02 PER SHARE FOR PUBLIC OFFER

* TO RAISE UP TO A$6.5 MILLION TO SUPPORT RESEARCH AND

DEVELOPMENT

OF TRYP'S LEAD PROGRAMS

Source text for Eikon:

Further company coverage: